Selective blockade of KCa3.1 using TRAM-34 inhibited chemotaxis of NK cells from both healthy donors and patients with HNSCC, while KCa3.1pharmacological activation increased chemotaxis and cytotoxicity. This evidence concerns the gene KCNN4 and head and neck squamous cell carcinoma.